[ad_1]
A breath of fresh air for cancer patients across the country. The Central Procurement Center for Essential Medicines and Medical Equipment of Madagascar (SALAMA) has announced that it will reduce the selling prices of anti-cancer drugs from this year to improve the economic accessibility of oncology products.
The average reduction in sales prices is around 55% overall. According to SALAMA, price cuts for some products range from 16% to 96% from the start of the year. Of the 51 references, 27 products have seen their selling prices reduced since the beginning of the year, and 14 new references requested by prescribers have been added.
The Madagascar Association for Radiotherapy and Oncology Support (AROM) is an important player in cancer care in Madagascar and is committed to providing better economic access to treatment for patients suffering from this disease. She believes that good quality, affordable and consistent treatment is the guarantee for improved treatment.
Many patients diagnosed with cancer are simply unable to seek treatment or continue care due to lack of resources. Due to the high cost of cancer treatment, patients often have to pay out of pocket to obtain treatment, which can result in financially catastrophic expenses. A full course of treatment can cost at least 10 million Ar (chemotherapy, radiotherapy, etc.).
Nearly 70% of cancer-related deaths occur in developing countries such as Madagascar. Globocan estimates that in 2021, there are 23,500 new cancer cases detected in the country each year, 50% of which are gynecological cancers.
[ad_2]
Source link
